The phrase "aims in developing" is not correct in standard written English.
It should be "aims to develop" instead.
Example: "The organization aims to develop innovative solutions for environmental sustainability."
Alternatives: "intends to develop" or "seeks to develop."
One of the main aims in developing new therapies is to use natural resources which have the ability to induce apoptosis.
One of the primary aims in developing the DB-CoMPP technique was to set up a method that allows a rapid screening of a collection of carbohydrate-binding proteins with unknown specificities towards a large variety of dedicated glycan samples.
As with any software tool, one of our aims in developing this new version of InterVA was to improve the scope of the tool and address known shortcomings of the previous version.
This multi-site study builds south south research collaboration within the INDEPTH Network and it aims in developing leadership capacity at all levels, gaining strong support from the community, and widening the network in achieving a successful chronic disease control programme.
An aim in developing low volatile organic compound (VOCs) emission house is to reduce the level of VOCs in domestic housing.
Results obtained from this investigation will contribute highly to the main research aim in developing an appropriate scope of work for the Interior Design practice.
Keynes's primary aim in developing his theory was to show that, under certain conditions the economy could become stuck in a disequilibrium, with productive resources in surplus (i.e., high level of unemployment) but income and output unable to rise sufficiently to reach an equilibrium.
Mr Hines says his aim in developing his robot's artificial intelligence engine, was to go beyond a simple sex aid and to provide companionship.
On the other hand, our aim in developing this system is to promote students' logical ability and thinking through posing problems instead of only solving problems.
A critical aim in developing therapeutic interventions for Alzheimer's Disease ADD) is the identification of suitable targets.
Our primary aim in developing data preprocessing tools is to help researchers with the manual annotation process that remains essential for nontarget metabolomics [ 54].
